This is a Validated Antibody Database (VAD) review about pig SIGLEC1, based on 3 published articles (read how Labome selects the articles), using SIGLEC1 antibody in all methods. It is aimed to help Labome visitors find the most suited SIGLEC1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SIGLEC1 synonym: SIGLEC-1; p210; pSn; sialoadhesin; Sialic acid-binding Ig-like lectin 1
Bio-Rad
mouse monoclonal (3B11/11) |
| In order to use CRISPR/Cas9 to generate pigs with a deletion of Exon 7 of the CD163 gene, encoding the scavenger receptor cysteine-rich domain 5, Bio-Rad SIGLEC1 antibody (AbD Serotec, MCA2316F) was used in flow cytometry on pig samples at 1:50 (fig 4b). PLoS Pathog (2017) ncbi |
mouse monoclonal (3B11/11) |
| Bio-Rad SIGLEC1 antibody (AbD Serotec, 3B11/11) was used in flow cytometry on pig samples (fig 3a). J Virol (2017) ncbi |
mouse monoclonal (3B11/11) |
| Bio-Rad SIGLEC1 antibody (AbD Serotec, MCA2316F) was used in flow cytometry on pig samples at 1:100 (fig 3c). Am J Physiol Gastrointest Liver Physiol (2016) ncbi |
Articles Reviewed
- Burkard C, Lillico S, Reid E, Jackson B, Mileham A, Ait Ali T, et al. Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathog. 2017;13:e1006206 pubmed publisher
- Wells K, Bardot R, Whitworth K, Trible B, Fang Y, Mileham A, et al. Replacement of Porcine CD163 Scavenger Receptor Cysteine-Rich Domain 5 with a CD163-Like Homolog Confers Resistance of Pigs to Genotype 1 but Not Genotype 2 Porcine Reproductive and Respiratory Syndrome Virus. J Virol. 2017;91: pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments